Researchers at the University of California-San Diego found that entacapone and tolcapone could potentially treat the drug-resistant strain of TB after discovering that the chemical structure of the two Parkinson"s drugs might work to target the TB enzyme InhA. In another experiment it was found that the active ingredient in the two drugs inhibited the M. tuberculosis bacterium while allowing host cells to survive.
저작권자 © 메디칼업저버 무단전재 및 재배포 금지